CiteFacts · FDA Drug Shortages · FDA source
FDA shortage status: Ropivacaine Hydrochloride Injection
FDA source answer
FDA currently lists this ingredient in shortage.
FDA source statuses: Current. First FDA posting: 2018-03-23. Latest FDA row update: 2026-10-02.
FDA lists 49 package records, with companies: Baxter Healthcare Corporation, Caplin Steriles, Ltd., Eugia US LLC, FRESENIUS KABI USA, LLC, Fresenius Kabi USA, LLC, InfoRLife SA, Sagent Pharmaceuticals, Somerset Therapeutics, LLC. Package NDCs: 25021-652-82, 25021-652-87, 25021-671-66, 25021-671-67, 25021-671-82, 25021-671-87, 43066-015-10, 43066-019-10, 43066-023-10, 43066-027-10, 55150-195-20, 55150-196-99, 55150-197-20, 55150-198-30, 55150-199-20, 55150-200-10, 55150-201-20, 63323-285-10, 63323-285-13, 63323-285-20, 63323-285-23, 63323-285-61, 63323-285-63, 63323-285-64, 63323-285-65, 63323-286-00, 63323-286-20, 63323-286-23, 63323-286-31, 63323-286-35, 63323-286-63, 63323-287-20, 63323-287-21, 63323-288-10, 63323-288-11, 63323-288-20, 63323-288-21, 65219-632-10, 65219-632-20, 70069-061-10, 70069-061-25, 70069-062-10, 70069-062-25, 70069-063-25, 70069-064-01, 70069-064-10, 70069-064-25, 70069-067-10, 70069-067-25.
FDA shortage reason: Delay in shipping of the drug; Demand increase for the drug; Other
This is nationwide FDA status, not local pharmacy inventory. CiteFacts does not provide medical, treatment, substitution, or dosing advice.
FDA package and manufacturer records
| Company | Package NDC | Presentation | FDA availability field | FDA update |
|---|---|---|---|---|
| Caplin Steriles, Ltd. | 43066-027-10 | Ropivacaine Hydrochloride, Injection, 10 mg/1 mL (NDC 43066-027-10) | Available | 2026-06-10 |
| Caplin Steriles, Ltd. | 43066-015-10 | Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 43066-015-10) | Limited Availability | 2026-06-10 |
| Caplin Steriles, Ltd. | 43066-019-10 | Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 43066-019-10) | Available | 2026-06-10 |
| Caplin Steriles, Ltd. | 43066-023-10 | Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 43066-023-10) | Limited Availability | 2026-06-10 |
| Eugia US LLC | 55150-200-10 | Ropivacaine Hydrochloride, Injection, 10 mg/1 mL (NDC 55150-200-10) | Available | 2026-10-02 |
| Eugia US LLC | 55150-201-20 | Ropivacaine Hydrochloride, Injection, 10 mg/1 mL (NDC 55150-201-20) | Available | 2026-10-02 |
| Eugia US LLC | 55150-195-20 | Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 55150-195-20) | Unavailable | 2026-10-02 |
| Eugia US LLC | 55150-196-99 | Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 55150-196-99) | Available | 2026-10-02 |
| Eugia US LLC | 55150-197-20 | Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 55150-197-20) | Available | 2026-10-02 |
| Eugia US LLC | 55150-198-30 | Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 55150-198-30) | Available | 2026-10-02 |
| Eugia US LLC | 55150-199-20 | Ropivacaine Hydrochloride, Injection, 7.5 mg/1 mL (NDC 55150-199-20) | Unavailable | 2026-10-02 |
| Fresenius Kabi USA, LLC | 63323-288-10 | Naropin, Injection, 10 mg/1 mL (NDC 63323-288-10) | Unavailable | 2026-09-15 |
| Fresenius Kabi USA, LLC | 63323-288-11 | Naropin, Injection, 10 mg/1 mL (NDC 63323-288-11) | Available | 2026-09-15 |
| Fresenius Kabi USA, LLC | 63323-288-20 | Naropin, Injection, 10 mg/1 mL (NDC 63323-288-20) | Unavailable | 2026-09-15 |
| Fresenius Kabi USA, LLC | 63323-288-21 | Naropin, Injection, 10 mg/1 mL (NDC 63323-288-21) | Available | 2026-09-15 |
| Fresenius Kabi USA, LLC | 63323-285-10 | Naropin, Injection, 2 mg/1 mL (NDC 63323-285-10) | Unavailable | 2026-09-15 |
| Fresenius Kabi USA, LLC | 63323-285-13 | Naropin, Injection, 2 mg/1 mL (NDC 63323-285-13) | Available | 2026-09-15 |
| Fresenius Kabi USA, LLC | 63323-285-20 | Naropin, Injection, 2 mg/1 mL (NDC 63323-285-20) | Unavailable | 2026-09-15 |
| Fresenius Kabi USA, LLC | 63323-285-23 | Naropin, Injection, 2 mg/1 mL (NDC 63323-285-23) | Available | 2026-09-15 |
| Fresenius Kabi USA, LLC | 63323-285-61 | Naropin, Injection, 2 mg/1 mL (NDC 63323-285-61) | Unavailable | 2026-09-15 |
| Fresenius Kabi USA, LLC | 63323-285-63 | Naropin, Injection, 2 mg/1 mL (NDC 63323-285-63) | Unavailable | 2026-09-15 |
| Fresenius Kabi USA, LLC | 63323-285-64 | Naropin, Injection, 2 mg/1 mL (NDC 63323-285-64) | Available | 2026-09-15 |
| Fresenius Kabi USA, LLC | 63323-285-65 | Naropin, Injection, 2 mg/1 mL (NDC 63323-285-65) | Available | 2026-09-15 |
| Fresenius Kabi USA, LLC | 65219-632-10 | Naropin, Injection, 2 mg/1 mL (NDC 65219-632-10) | Available | 2026-09-15 |
| Fresenius Kabi USA, LLC | 65219-632-20 | Naropin, Injection, 2 mg/1 mL (NDC 65219-632-20) | Available | 2026-09-15 |
| Fresenius Kabi USA, LLC | 63323-286-00 | Naropin, Injection, 5 mg/1 mL (NDC 63323-286-00) | Available | 2026-09-15 |
| Fresenius Kabi USA, LLC | 63323-286-20 | Naropin, Injection, 5 mg/1 mL (NDC 63323-286-20) | Unavailable | 2026-09-15 |
| Fresenius Kabi USA, LLC | 63323-286-23 | Naropin, Injection, 5 mg/1 mL (NDC 63323-286-23) | Available | 2026-09-15 |
| Fresenius Kabi USA, LLC | 63323-286-31 | Naropin, Injection, 5 mg/1 mL (NDC 63323-286-31) | Unavailable | 2026-09-15 |
| Fresenius Kabi USA, LLC | 63323-286-35 | Naropin, Injection, 5 mg/1 mL (NDC 63323-286-35) | Available | 2026-09-15 |
| Fresenius Kabi USA, LLC | 63323-286-63 | Naropin, Injection, 5 mg/1 mL (NDC 63323-286-63) | Available | 2026-09-15 |
| Fresenius Kabi USA, LLC | 63323-287-20 | Naropin, Injection, 7.5 mg/1 mL (NDC 63323-287-20) | Unavailable | 2026-09-15 |
| Fresenius Kabi USA, LLC | 63323-287-21 | Naropin, Injection, 7.5 mg/1 mL (NDC 63323-287-21) | Available | 2026-09-15 |
| InfoRLife SA | 25021-671-66 | Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 25021-671-66) | Limited Availability | 2026-08-18 |
| InfoRLife SA | 25021-671-67 | Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 25021-671-67) | Unavailable | 2026-08-18 |
| InfoRLife SA | 25021-671-82 | Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 25021-671-82) | Available | 2026-08-18 |
| InfoRLife SA | 25021-671-87 | Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 25021-671-87) | Available | 2026-08-18 |
| InfoRLife SA | 25021-652-82 | Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 25021-652-82) | Available | 2026-08-18 |
| InfoRLife SA | 25021-652-87 | Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 25021-652-87) | Available | 2026-08-18 |
| Somerset Therapeutics, LLC | 70069-067-10 | Ropivacaine Hydrochloride, Injection, 10 mg/1 mL (NDC 70069-067-10) | Available | 2026-09-11 |
| Somerset Therapeutics, LLC | 70069-067-25 | Ropivacaine Hydrochloride, Injection, 10 mg/1 mL (NDC 70069-067-25) | Available | 2026-09-11 |
| Somerset Therapeutics, LLC | 70069-061-10 | Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 70069-061-10) | Available | 2026-09-11 |
| Somerset Therapeutics, LLC | 70069-061-25 | Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 70069-061-25) | Available | 2026-09-11 |
| Somerset Therapeutics, LLC | 70069-062-10 | Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 70069-062-10) | Available | 2026-09-11 |
| Somerset Therapeutics, LLC | 70069-062-25 | Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 70069-062-25) | Available | 2026-09-11 |
| Somerset Therapeutics, LLC | 70069-063-25 | Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 70069-063-25) | Available | 2026-09-11 |
| Somerset Therapeutics, LLC | 70069-064-01 | Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 70069-064-01) | Available | 2026-09-11 |
| Somerset Therapeutics, LLC | 70069-064-10 | Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 70069-064-10) | Available | 2026-09-11 |
| Somerset Therapeutics, LLC | 70069-064-25 | Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 70069-064-25) | Available | 2026-09-11 |
Source facts
Grouped generic ingredient: Ropivacaine Hydrochloride Injection · 49 package records
Therapeutic categories: Anesthesia
Dosage forms: Injection
Routes: EPIDURAL, INFILTRATION, PERINEURAL
Open FDA source data · JSON · Markdown
FDA is authoritative. Source retrieved 2026-10-06T18:55:41+00:00. Derived grouping is documented in this record's derivations.